Cargando…
PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study
Autores principales: | Mozaffari, E., Chandak, A., Liang, S., Gayle, J., Haubrich, R., Thrun, M., Hodgkins, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177612/ http://dx.doi.org/10.1016/j.jval.2021.04.1270 |
Ejemplares similares
-
POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19
por: Mozaffari, E, et al.
Publicado: (2022) -
38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality
por: Mozaffari, Essy, et al.
Publicado: (2021) -
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort
por: Mozaffari, Essy, et al.
Publicado: (2021) -
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations
por: Read, Stephanie H, et al.
Publicado: (2021) -
POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients
por: Mozaffari, E, et al.
Publicado: (2022)